EVALUATING THE EFFICACY OF MYSUGR IN A RANDOMIZED CONTROLLED TRIAL: BASELINE CHARACTERISTICS

被引：0
|
作者：
Ehrmann, D. [1 ]
Kulzer, B. [1 ]
Silbermann, S. [2 ]
Kober, J. [2 ,3 ]
Finke-Grone, K. [1 ]
Roos, T. [1 ]
Vesper, I. [2 ]
Schafer, V. [4 ]
Hermanns, N. [1 ]
机构：
[1] FIDAM GmbH, Forschungsinst Diabet Akad Bad Mergentheim, Bad Mergentheim, Germany
[2] Roche Diabet Care GmbH, Mannheim, Germany
[3] MySugr GmbH, Vienna, Austria
[4] Roche Diabet Care Deutschland GmbH, Mannheim, Germany
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
871
引用
下载
收藏
页码：A66 / A66
页数：1
相关论文
共 50 条
  • [1] SATISFACTION WITH MYSUGR IN THE INTERVENTION GROUP OF A RANDOMIZED CONTROLLED TRIAL
    Hermanns, N.
    Ehrmann, D.
    Silbermann, S.
    Kober, J.
    Finke-Groene, K.
    Roos, T.
    Bingol, E.
    Schaefer, V.
    Kulzer, B.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A78 - A78
  • [2] A RANDOMIZED CONTROLLED TRIAL TO TEST THE EFFICACY OF A TITRATION APP FOR PEOPLE WITH TYPE 2 DIABETES: BASELINE CHARACTERISTICS
    Hermanns, N.
    Ehrmann, D.
    Groene, K. Finke
    Roos, T.
    Kulzer, B.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A98 - A99
  • [3] Baseline characteristics of adults with neurofibromatosis enrolled on a psychosocial randomized controlled trial
    Nathan S. Fishbein
    Ana-Maria Vranceanu
    Ryan A. Mace
    Journal of Neuro-Oncology, 2022, 159 : 637 - 646
  • [4] Baseline characteristics of adults with neurofibromatosis enrolled on a psychosocial randomized controlled trial
    Fishbein, Nathan S.
    Vranceanu, Ana-Maria
    Mace, Ryan A.
    JOURNAL OF NEURO-ONCOLOGY, 2022, 159 (03) : 637 - 646
  • [5] Comparison of baseline patient characteristics of the CONVINCE randomized controlled trial with existing trial and registry populations
    Yuen, Tom
    Pham, Ngoc
    Ho, Kakiu
    Braun, Jennifer
    Stauss-Grabo, Manuela
    Strippoli, Giovanni
    Cromm, Krister
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1380 - I1381
  • [6] Protocol update and baseline characteristics for the TRIal to slow the Progression of Diabetes (TRIPOD) randomized controlled trial
    Joann Bairavi
    Daphne Su-Lyn Gardner
    Ester Yeoh
    Kwang Wei Tham
    Mihir Gandhi
    Ngiap Chuan Tan
    Phong Ching Lee
    Robyn Su May Lim
    Thofique Adamjee
    Yin Bun Cheung
    Yong Mong Bee
    Eric Andrew Finkelstein
    Trials, 24
  • [7] Protocol update and baseline characteristics for the TRIal to slow the Progression of Diabetes (TRIPOD) randomized controlled trial
    Bairavi, Joann
    Gardner, Daphne Su-Lyn
    Yeoh, Ester
    Tham, Kwang Wei
    Gandhi, Mihir
    Tan, Ngiap Chuan
    Lee, Phong Ching
    Lim, Robyn Su May
    Adamjee, Thofique
    Cheung, Yin Bun
    Bee, Yong Mong
    Finkelstein, Eric Andrew
    TRIALS, 2023, 24 (01)
  • [8] A randomized controlled trial evaluating the efficacy of a 67% sodium bicarbonate toothpaste on gingivitis
    Lomax, A.
    Patel, S.
    Wang, N.
    Kakar, K.
    Kakar, A.
    Bosma, M. L.
    INTERNATIONAL JOURNAL OF DENTAL HYGIENE, 2017, 15 (04) : e35 - e41
  • [9] Evaluating the efficacy of an attention modification program for patients with fibromyalgia: a randomized controlled trial
    Carleton, R. Nicholas
    Asmundson, Gordon J. G.
    Korol, Stephanie L.
    LeBouthillier, Daniel M.
    Hozempa, Kadie
    Katz, Joel D.
    Vlaeyen, Johan W. S.
    Crombez, Geert
    PAIN, 2020, 161 (03) : 584 - 594
  • [10] Laser in Glaucoma and Ocular Hypertension Trial (LIGHT) in China - A Randomized Controlled Trial: Design and Baseline Characteristics
    Yang, Yangfan
    Jiang, Yuzhen
    Huang, Shitong
    Zhang, Xinyi
    Nathwani, Neil
    Lin, Mingkai
    Liu, Xing
    Zhang, Xiulan
    Fan, Yanmei
    Xu, Jiangang
    Gazzard, Gus
    Yu, Minbin
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2021, 230 : 143 - 150
12345